VC

Vivo Capital Portfolio holdings

AUM $977M
1-Year Return 209.68%
This Quarter Return
+16.26%
1 Year Return
+209.68%
3 Year Return
+1,480.07%
5 Year Return
+2,591.98%
10 Year Return
AUM
$992M
AUM Growth
+$216M
Cap. Flow
+$209M
Cap. Flow %
21.1%
Top 10 Hldgs %
62.98%
Holding
46
New
6
Increased
7
Reduced
8
Closed
2
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
ZYME icon
26
Zymeworks
ZYME
$1.19B
$9.74M 0.98%
620,134
SLNO icon
27
Soleno Therapeutics
SLNO
$2.85B
$9.42M 0.95%
290,646
DCPH
28
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$8.23M 0.83%
212,648
-40,294
-16% -$1.56M
AUPH icon
29
Aurinia Pharmaceuticals
AUPH
$1.68B
$8.06M 0.81%
1,213,290
KNSA icon
30
Kiniksa Pharmaceuticals
KNSA
$2.75B
$6.75M 0.68%
264,878
+78,805
+42% +$2.01M
GNCA
31
DELISTED
Genocea Biosciences, Inc.
GNCA
$6.38M 0.64%
1,022,500
ZGNX
32
DELISTED
Zogenix, Inc.
ZGNX
$5.21M 0.52%
105,000
ARVN icon
33
Arvinas
ARVN
$568M
$5.06M 0.51%
+300,000
New +$5.06M
ZLAB icon
34
Zai Lab
ZLAB
$3.65B
$4.5M 0.45%
231,010
SBBP
35
DELISTED
Strongbridge Biopharma plc.
SBBP
$4.45M 0.45%
918,132
-1,000,000
-52% -$4.85M
SRRA
36
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$4.15M 0.42%
60,957
TRVN
37
DELISTED
Trevena, Inc.
TRVN
$3.66M 0.37%
2,765
TMBR
38
DELISTED
Timber Pharmaceuticals, Inc.
TMBR
$3.06M 0.31%
1,075
FOMX
39
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$2.45M 0.25%
427,500
-427,500
-50% -$2.45M
AKTX
40
Akari Therapeutics
AKTX
$25.7M
$885K 0.09%
17,293
AGRX
41
DELISTED
Agile Therapeutics, Inc
AGRX
$555K 0.06%
757
VIRX
42
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$391K 0.04%
5,585
ONCT
43
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$165K 0.02%
+750
New +$165K
SLNOW
44
DELISTED
Soleno Therapeutics, Inc. Series A Warrant
SLNOW
$23K ﹤0.01%
188,772
MDGL icon
45
Madrigal Pharmaceuticals
MDGL
$9.63B
-62,220
Closed -$17.4M
RGNX icon
46
Regenxbio
RGNX
$465M
-82,403
Closed -$5.91M